Design of Phosphorodiamidate Morpholino Oligomers (PMOs) for the Induction of Exon Skipping of the Human DMD Gene

This publication has 35 references indexed in Scilit:

• Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice
  Molecular Therapy, 2008
• Dynamics of Co-Transcriptional Pre-mRNA Folding Influences the Induction of Dystrophin Exon Skipping by Antisense Oligonucleotides
  PLOS ONE, 2008
• Antisense Oligonucleotide-induced Exon Skipping Across the Human Dystrophin Gene Transcript
  Molecular Therapy, 2007
• Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries
  BMC Molecular Biology, 2007
• The Influence of Antisense Oligonucleotide Length on Dystrophin Exon Skipping
  Molecular Therapy, 2007
• Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
  Gene Therapy, 2006
• Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
  Nature Medicine, 2006
• Functional Analysis of 114 Exon-Internal AONs for Targeted DMD Exon Skipping: Indication for Steric Hindrance of SR Protein Binding Sites
  Oligonucleotides, 2005
• Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide
  The Journal of Gene Medicine, 2005
• Targeted Exon Skipping in Transgenic hDMD Mice: A Model for Direct Preclinical Screening of Human-Specific Antisense Oligonucleotides
  Molecular Therapy, 2004